Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2000 participants
OBSERVATIONAL
2013-11-30
2022-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Standardising Care for Hepatitis Delta in the Netherlands
NCT05903742
DELTA DESCRIBE: the French Collaborative Project
NCT05936073
Delta Hepatitis and Liver Disease in Hemophiliacs
NCT00005304
Find HDV and Determine Its Status in Turkey
NCT06248580
Hepatitis Delta Infections in Hemophiliacs
NCT00005305
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aims of this project are:
i. Collect clinical information from hepatitis delta patients from multiple centers distributed worldwide in order to build up a large database that will enable and facilitate further research on chronic hepatitis delta.
ii. To better inform patients about their viral infection, present status and evolution of liver disease throughout time. To give them the tools needed to inform other peers and medical professionals about the significance and consequences of a chronic hepatitis delta infection.
iii. To allow the participating physicians to track course of the disease, therapies, signs and symptoms of the hepatitis delta patients included by their center.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Center for Infection Research
OTHER
Hannover Medical School
OTHER
HepNet Study House, German Liverfoundation
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael P Manns, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Hannover Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Vienna; Internal Med.III
Vienna, , Austria
Antwerpen University Hospital
Edegem, , Belgium
Centro de Pesquisa em Medicina Tropical
Rondônia, , Brazil
Medical Center Mrcheveli
Tbilisi, , Georgia
Medizinisches Infektiologiezentrum
Berlin, , Germany
Medizinische Klinik I Charite- Campus Benjamin Franklin
Berlin, , Germany
Universitätsklinikum Giessen-Marburg
Giessen, , Germany
Medizinische Hochschule Hannover
Hanover, , Germany
Dep.of Medicine University of Thessalony
Larissa, , Greece
Centro di ricerca per lo studio della Epatiti
Bologna, , Italy
Gastroenterology Casa Sollievo della Sofferenza Hospital
San Giovanni Rotondo, , Italy
A.O.U. Citta della Salute e della Scienza di Torino
Torino, , Italy
The University of Medicine "Nicolae Testimitanu"
Chisinau, , Moldova
Dept.of Medicine Aga Khan University
Karachi, , Pakistan
Liverstomach Clinic
Karachi, , Pakistan
Clinical Hospital of Infectious Disease "dr. Victor Babes"
Bucharest, , Romania
Hospital Vall d´Hebron
Barcelona, , Spain
Vietnamese-German Center for Medical Research
Hanoi, , Vietnam
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wranke A, Pinheiro Borzacov LM, Parana R, Lobato C, Hamid S, Ceausu E, Dalekos GN, Rizzetto M, Turcanu A, Niro GA, Lubna F, Abbas M, Ingiliz P, Buti M, Ferenci P, Vanwolleghem T, Hayden T, Dashdorj N, Motoc A, Cornberg M, Abbas Z, Yurdaydin C, Manns MP, Wedemeyer H, Hardtke S; Hepatitis Delta International Network. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN). Liver Int. 2018 May;38(5):842-850. doi: 10.1111/liv.13604. Epub 2017 Oct 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HepNet-HDIN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.